title: Treatment strategies in toxic epidermal necrolysis syndrome: where are we at?
abstract: Toxic epidermal necrolysis syndrome (TENS) is a rare, life-threatening medical emergency typically associated with recent drug exposure. Although several theories exist, recent insight has implicated the innate immune system as a significant contributor to the initiation and propagation of this devastating reaction. Standard therapies including transfer to specialized burn units, nutritional support, and protection from infection, remain the mainstay in the treatment of TENS. While alternative treatment strategies have been pursued and reported, there remains no published data that convincingly supports these further interventions. Given the rare nature of this syndrome, multi-institutional studies will be necessary and essential in improving the understanding and treatment of TENS.
authors.affiliation: Department of Surgery, Loyola University Medical Center, Maywood, Illinois 60153, USA.
authors.forename: Gerard J
authors.initials: GJ
authors.lastname: Abood
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Nickoloff
authors.forename: Richard L
authors.initials: RL
authors.lastname: Gamelli
mesh_terms: D002053:Burn Units; D002056:Burns / Q000150:complications* / Q000503:physiopathology; D006801:Humans; D018529:Nutritional Support; D011379:Prognosis; D013262:Stevens-Johnson Syndrome / Q000209:etiology / Q000401:mortality / Q000628:therapy*